Pharmaceutical Contract Manufacturing Market
PUBLISHED: 2023 ID: SMRC23020
SHARE
SHARE

Pharmaceutical Contract Manufacturing Market

Pharmaceutical Contract Manufacturing Market Forecasts to 2028 - Global Analysis By Service (Active Pharmaceutical Ingredient (API) Manufacturing, Finished Dosage Formulation (FDF) Development & Manufacturing, Drug Discovery, Preclinical Studies, Medical Coding & Writing, Monitoring, Clinical Data Management, Bio-Statistics, Site Management and Protocol Development), Molecule Type (Small Molecules and Large Molecules), End User and By Geography

4.8 (20 reviews)
4.8 (20 reviews)
Published: 2023 ID: SMRC23020

This report covers the impact of COVID-19 on this global market
Loading...

Years Covered

2020-2028

Estimated Year Value (2022)

US $143.02 BN

Projected Year Value (2028)

US $210.34 BN

CAGR (2022 - 2028)

6.6%

Regions Covered

North America, Europe, Asia Pacific, South America, and Middle East & Africa

Countries Covered

US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa

Largest Market

North America

Highest Growing Market

Asia Pacific


According to Stratistics MRC, the Global Pharmaceutical Contract Manufacturing Market is accounted for $143.02 billion in 2022 and is expected to reach $210.34 billion by 2028 growing at a CAGR of 6.6% during the forecast period. Pharmaceutical contract manufacturing is the method through which pharmaceutical medications are made under contract. It is the practice of contracting out the job of creating medicine including pills, tablets and capsules for consumption by a third party. A variety of services such as drug development, manufacturing, and commercial production, documentation of compliance with FDA regulatory standards, and pre-formulation are offered by pharma contract manufacturing businesses to pharmaceutical corporations. It relieves pharmaceutical companies from the cost and burden of hiring and training workers during periods of labor shortage.

According to the CPhI Pharma Index 2020, India is the primary beneficiary of API manufacturing and CRO chemistry services outsourcing, rebalancing away from China.



Market Dynamics:

Driver:

High cost of in-house drug development

For small- and medium-sized pharmaceutical enterprises, the process of drug research and development is highly costly and time-consuming. The cost of producing the formulation and developing drugs internally goes up as a result. Factors such as high failure rates for medications, high costs of discovery and lack of funding forces the pharmaceutical firms to outsource their drug development procedures to pharmaceutical contract manufacturing which propels the market's expansion.

Restraint:

Compliance with regulatory guidelines

Poor quality of produced pharmaceuticals and the related authority’s noncompliance with standards and regulations has major ramifications for the company and its brand name. In the pharmaceutical sector, the contractor's brand is used to market the manufactured medication ingredient or formulation. Large volumes of data must be given to the regulatory authorities in order to accomplish properly. Data processing and submissions of various formulas become challenging, which raises the possibility of regulatory filing mistakes. This aspect will probably impede market expansion.

Opportunity:

Raising demand in major economies

Since the labor costs and manpower advantages, emerging nations are centers for outsourcing bioprocesses. Competitive companies are encouraged to engage in developing markets by the availability of modern manufacturing technology and the cheap production and labor costs offered by emerging nations. Further the growing interest of pharmaceutical companies in outsourcing drug discovery due to the constant rise in vaccine demand, drying up of the pipeline for antibiotics, and rising R&D costs is fueling the market expansion.

Threat:

Implementation of serialization


Serialization is the act of providing each service or product item a unique identification by utilizing a specified coding type, enabling it to be tracked and traced along the supply chain. The implementation of a reliable pharma serialization solution necessitates a substantial financial investment in software, hardware, employee training, and manufacturing lines that are properly prepared. Consequently, the market might encounter a problem as a result.

Covid-19 Impact

Several healthcare markets were either favourably or badly influenced by the COVID-19 epidemic. But the pharmaceutical contract development and manufacturing business has benefited hugely. The outbreak sparked the development of various pharmaceutical products, including antiviral vaccines, antibody therapies, and corona virus-related vaccines. To ensure the long-term viability of their businesses, pharmaceutical companies were encouraged to work with contract development and manufacturing companies.

The active pharmaceutical ingredient (API) manufacturing segment is expected to be the largest during the forecast period

The active pharmaceutical ingredient (API) manufacturing segment is estimated to have a lucrative growth. API is the acetaminophen contained in a painkiller pill. APIs are produced by processing chemical compounds. It is an active component in a pharmaceutical drug that produces the required effect on the body to treat a condition. Its therapeutic impact and improved preventative care is accelerating the segment’s growth.

The big pharma segment is expected to have the highest CAGR during the forecast period

The big pharma segment is anticipated to witness the fastest CAGR growth during the forecast period. Growing investment in the development of cell and gene therapies, an increase in the number of biologics undergoing pipeline investigations and the rising need for targeted pharmacological treatments are the key factors projected to propel the segment’s expansion.

Region with largest share:

North America is projected to hold the largest market share during the forecast period. A significant number of pharmaceutical businesses operate in this area. Generics are in extremely high demand, and as a result, research funding for pharmaceutical contract development and manufacture has skyrocketed. The cash-rich character of American businesses is to blame for the industry's monopoly status in contract manufacturing.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period, owing to the spout of significant investments. Due to their rising manufacturing capabilities, nations like Singapore, China and India have been identified as important participants in the pharmaceutical sector. This expansion is made possible by an increase in the number of businesses outsourcing work to these nation’s emerging economies.



Key players in the market

Some of the key players profiled in the Pharmaceutical Contract Manufacturing Market include Thermo Fisher Scientific Inc, Boehringer Ingelheim Group, Lonza Group AG, Accenture plc, Catalent Inc, Pfizer CentreSource, Cognizant Technology Solutions, ATOS SE, Catalent, Inc., Covance, Inc, Genpact Limited, Quintiles Transnational Corporation, Abbvie, Inc., Baxter International Inc., Reddy’s Laboratories Ltd., Aurobindo Pharma, Pfizer, Inc., The Almac Group, Teva Pharmaceutical Industries Ltd. and Piramal Enterprises Ltd.

Key Developments:

In May 2023, Accenture has agreed to acquire Objectivity, a digital engineering firm specializing in cloud and platform development services that help clients accelerate their transformation journey for rapid innovation.

In March 2023, Aurobindo Pharma announced that its subsidiary Eugia Pharma Specialities has received final approval from the U.S. Food and Drug Administration (U.S. FDA) to manufacture and market cancer drug Lenalidomide Capsules, in different strengths.

In September 2022, Thermo Fisher Scientific Inc. unveiled the Thermo Scientific™ DynaSpin™ Single-Use Centrifuge system at the Bioprocess International annual conference in Boston, MA. The system is specifically designed to provide an optimal single-use solution for large-scale cell culture harvesting.

Services Covered:
• Active Pharmaceutical Ingredient (API) Manufacturing
• Finished Dosage Formulation (FDF) Development & Manufacturing
• Drug Discovery
• Preclinical Studies
• Medical Coding & Writing
• Monitoring
• Clinical Data Management
• Bio-Statistics
• Site Management
• Protocol Development

Molecule Types Covered:
• Small Molecules
• Large Molecules

End Users Covered:
• Big Pharma
• Small & Medium Sized Pharma
• Generic Pharma

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Pharmaceutical Contract Manufacturing Market, By Service
5.1 Introduction
5.2 Active Pharmaceutical Ingredient (API) Manufacturing
5.3 Finished Dosage Formulation (FDF) Development & Manufacturing
5.4 Drug Discovery
5.5 Preclinical Studies
5.6 Medical Coding & Writing
5.7 Monitoring
5.8 Clinical Data Management
5.9 Bio-Statistics
5.10 Site Management
5.11 Protocol Development

6 Global Pharmaceutical Contract Manufacturing Market, By Molecule Type
6.1 Introduction
6.2 Small Molecules
6.3 Large Molecules

7 Global Pharmaceutical Contract Manufacturing Market, By End User
7.1 Introduction
7.2 Big Pharma
7.3 Small & Medium Sized Pharma
7.4 Generic Pharma

8 Global Pharmaceutical Contract Manufacturing Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa

9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling
10.1 Thermo Fisher Scientific Inc
10.2 Boehringer Ingelheim Group
10.3 Lonza Group AG
10.4 Accenture plc
10.5 Catalent Inc
10.6 Pfizer CentreSource
10.7 Cognizant Technology Solutions
10.8 ATOS SE
10.9 Catalent, Inc.
10.10 Covance, Inc
10.11 Genpact Limited
10.12 Quintiles Transnational Corporation
10.13 Abbvie, Inc.
10.14 Baxter International Inc.
10.15 Reddy’s Laboratories Ltd.
10.16 Aurobindo Pharma
10.17 Pfizer, Inc.
10.18 The Almac Group
10.19 Teva Pharmaceutical Industries Ltd.
10.20 Piramal Enterprises Ltd

List of Tables
1 Global Pharmaceutical Contract Manufacturing Market Outlook, By Region (2020-2028) ($MN)
2 Global Pharmaceutical Contract Manufacturing Market Outlook, By Service (2020-2028) ($MN)
3 Global Pharmaceutical Contract Manufacturing Market Outlook, By Active Pharmaceutical Ingredient (API) Manufacturing (2020-2028) ($MN)
4 Global Pharmaceutical Contract Manufacturing Market Outlook, By Finished Dosage Formulation (FDF) Development & Manufacturing (2020-2028) ($MN)
5 Global Pharmaceutical Contract Manufacturing Market Outlook, By Drug Discovery (2020-2028) ($MN)
6 Global Pharmaceutical Contract Manufacturing Market Outlook, By Preclinical Studies (2020-2028) ($MN)
7 Global Pharmaceutical Contract Manufacturing Market Outlook, By Medical Coding & Writing (2020-2028) ($MN)
8 Global Pharmaceutical Contract Manufacturing Market Outlook, By Monitoring (2020-2028) ($MN)
9 Global Pharmaceutical Contract Manufacturing Market Outlook, By Clinical Data Management (2020-2028) ($MN)
10 Global Pharmaceutical Contract Manufacturing Market Outlook, By Bio-Statistics (2020-2028) ($MN)
11 Global Pharmaceutical Contract Manufacturing Market Outlook, By Site Management (2020-2028) ($MN)
12 Global Pharmaceutical Contract Manufacturing Market Outlook, By Protocol Development (2020-2028) ($MN)
13 Global Pharmaceutical Contract Manufacturing Market Outlook, By Molecule Type (2020-2028) ($MN)
14 Global Pharmaceutical Contract Manufacturing Market Outlook, By Small Molecules (2020-2028) ($MN)
15 Global Pharmaceutical Contract Manufacturing Market Outlook, By Large Molecules (2020-2028) ($MN)
16 Global Pharmaceutical Contract Manufacturing Market Outlook, By End User (2020-2028) ($MN)
17 Global Pharmaceutical Contract Manufacturing Market Outlook, By Big Pharma (2020-2028) ($MN)
18 Global Pharmaceutical Contract Manufacturing Market Outlook, By Small & Medium Sized Pharma (2020-2028) ($MN)
19 Global Pharmaceutical Contract Manufacturing Market Outlook, By Generic Pharma (2020-2028) ($MN)
20 North America Pharmaceutical Contract Manufacturing Market Outlook, By Country (2020-2028) ($MN)
21 North America Pharmaceutical Contract Manufacturing Market Outlook, By Service (2020-2028) ($MN)
22 North America Pharmaceutical Contract Manufacturing Market Outlook, By Active Pharmaceutical Ingredient (API) Manufacturing (2020-2028) ($MN)
23 North America Pharmaceutical Contract Manufacturing Market Outlook, By Finished Dosage Formulation (FDF) Development & Manufacturing (2020-2028) ($MN)
24 North America Pharmaceutical Contract Manufacturing Market Outlook, By Drug Discovery (2020-2028) ($MN)
25 North America Pharmaceutical Contract Manufacturing Market Outlook, By Preclinical Studies (2020-2028) ($MN)
26 North America Pharmaceutical Contract Manufacturing Market Outlook, By Medical Coding & Writing (2020-2028) ($MN)
27 North America Pharmaceutical Contract Manufacturing Market Outlook, By Monitoring (2020-2028) ($MN)
28 North America Pharmaceutical Contract Manufacturing Market Outlook, By Clinical Data Management (2020-2028) ($MN)
29 North America Pharmaceutical Contract Manufacturing Market Outlook, By Bio-Statistics (2020-2028) ($MN)
30 North America Pharmaceutical Contract Manufacturing Market Outlook, By Site Management (2020-2028) ($MN)
31 North America Pharmaceutical Contract Manufacturing Market Outlook, By Protocol Development (2020-2028) ($MN)
32 North America Pharmaceutical Contract Manufacturing Market Outlook, By Molecule Type (2020-2028) ($MN)
33 North America Pharmaceutical Contract Manufacturing Market Outlook, By Small Molecules (2020-2028) ($MN)
34 North America Pharmaceutical Contract Manufacturing Market Outlook, By Large Molecules (2020-2028) ($MN)
35 North America Pharmaceutical Contract Manufacturing Market Outlook, By End User (2020-2028) ($MN)
36 North America Pharmaceutical Contract Manufacturing Market Outlook, By Big Pharma (2020-2028) ($MN)
37 North America Pharmaceutical Contract Manufacturing Market Outlook, By Small & Medium Sized Pharma (2020-2028) ($MN)
38 North America Pharmaceutical Contract Manufacturing Market Outlook, By Generic Pharma (2020-2028) ($MN)
39 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Country (2020-2028) ($MN)
40 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Service (2020-2028) ($MN)
41 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Active Pharmaceutical Ingredient (API) Manufacturing (2020-2028) ($MN)
42 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Finished Dosage Formulation (FDF) Development & Manufacturing (2020-2028) ($MN)
43 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Drug Discovery (2020-2028) ($MN)
44 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Preclinical Studies (2020-2028) ($MN)
45 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Medical Coding & Writing (2020-2028) ($MN)
46 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Monitoring (2020-2028) ($MN)
47 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Clinical Data Management (2020-2028) ($MN)
48 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Bio-Statistics (2020-2028) ($MN)
49 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Site Management (2020-2028) ($MN)
50 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Protocol Development (2020-2028) ($MN)
51 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Molecule Type (2020-2028) ($MN)
52 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Small Molecules (2020-2028) ($MN)
53 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Large Molecules (2020-2028) ($MN)
54 Europe Pharmaceutical Contract Manufacturing Market Outlook, By End User (2020-2028) ($MN)
55 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Big Pharma (2020-2028) ($MN)
56 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Small & Medium Sized Pharma (2020-2028) ($MN)
57 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Generic Pharma (2020-2028) ($MN)
58 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Country (2020-2028) ($MN)
59 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Service (2020-2028) ($MN)
60 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Active Pharmaceutical Ingredient (API) Manufacturing (2020-2028) ($MN)
61 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Finished Dosage Formulation (FDF) Development & Manufacturing (2020-2028) ($MN)
62 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Drug Discovery (2020-2028) ($MN)
63 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Preclinical Studies (2020-2028) ($MN)
64 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Medical Coding & Writing (2020-2028) ($MN)
65 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Monitoring (2020-2028) ($MN)
66 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Clinical Data Management (2020-2028) ($MN)
67 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Bio-Statistics (2020-2028) ($MN)
68 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Site Management (2020-2028) ($MN)
69 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Protocol Development (2020-2028) ($MN)
70 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Molecule Type (2020-2028) ($MN)
71 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Small Molecules (2020-2028) ($MN)
72 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Large Molecules (2020-2028) ($MN)
73 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By End User (2020-2028) ($MN)
74 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Big Pharma (2020-2028) ($MN)
75 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Small & Medium Sized Pharma (2020-2028) ($MN)
76 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Generic Pharma (2020-2028) ($MN)
77 South America Pharmaceutical Contract Manufacturing Market Outlook, By Country (2020-2028) ($MN)
78 South America Pharmaceutical Contract Manufacturing Market Outlook, By Service (2020-2028) ($MN)
79 South America Pharmaceutical Contract Manufacturing Market Outlook, By Active Pharmaceutical Ingredient (API) Manufacturing (2020-2028) ($MN)
80 South America Pharmaceutical Contract Manufacturing Market Outlook, By Finished Dosage Formulation (FDF) Development & Manufacturing (2020-2028) ($MN)
81 South America Pharmaceutical Contract Manufacturing Market Outlook, By Drug Discovery (2020-2028) ($MN)
82 South America Pharmaceutical Contract Manufacturing Market Outlook, By Preclinical Studies (2020-2028) ($MN)
83 South America Pharmaceutical Contract Manufacturing Market Outlook, By Medical Coding & Writing (2020-2028) ($MN)
84 South America Pharmaceutical Contract Manufacturing Market Outlook, By Monitoring (2020-2028) ($MN)
85 South America Pharmaceutical Contract Manufacturing Market Outlook, By Clinical Data Management (2020-2028) ($MN)
86 South America Pharmaceutical Contract Manufacturing Market Outlook, By Bio-Statistics (2020-2028) ($MN)
87 South America Pharmaceutical Contract Manufacturing Market Outlook, By Site Management (2020-2028) ($MN)
88 South America Pharmaceutical Contract Manufacturing Market Outlook, By Protocol Development (2020-2028) ($MN)
89 South America Pharmaceutical Contract Manufacturing Market Outlook, By Molecule Type (2020-2028) ($MN)
90 South America Pharmaceutical Contract Manufacturing Market Outlook, By Small Molecules (2020-2028) ($MN)
91 South America Pharmaceutical Contract Manufacturing Market Outlook, By Large Molecules (2020-2028) ($MN)
92 South America Pharmaceutical Contract Manufacturing Market Outlook, By End User (2020-2028) ($MN)
93 South America Pharmaceutical Contract Manufacturing Market Outlook, By Big Pharma (2020-2028) ($MN)
94 South America Pharmaceutical Contract Manufacturing Market Outlook, By Small & Medium Sized Pharma (2020-2028) ($MN)
95 South America Pharmaceutical Contract Manufacturing Market Outlook, By Generic Pharma (2020-2028) ($MN)
96 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Country (2020-2028) ($MN)
97 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Service (2020-2028) ($MN)
98 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Active Pharmaceutical Ingredient (API) Manufacturing (2020-2028) ($MN)
99 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Finished Dosage Formulation (FDF) Development & Manufacturing (2020-2028) ($MN)
100 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Drug Discovery (2020-2028) ($MN)
101 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Preclinical Studies (2020-2028) ($MN)
102 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Medical Coding & Writing (2020-2028) ($MN)
103 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Monitoring (2020-2028) ($MN)
104 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Clinical Data Management (2020-2028) ($MN)
105 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Bio-Statistics (2020-2028) ($MN)
106 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Site Management (2020-2028) ($MN)
107 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Protocol Development (2020-2028) ($MN)
108 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Molecule Type (2020-2028) ($MN)
109 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Small Molecules (2020-2028) ($MN)
110 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Large Molecules (2020-2028) ($MN)
111 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By End User (2020-2028) ($MN)
112 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Big Pharma (2020-2028) ($MN)
113 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Small & Medium Sized Pharma (2020-2028) ($MN)
114 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Generic Pharma (2020-2028) ($MN)

List of Figures

RESEARCH METHODOLOGY


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials